JBC Avanti Polar Lipids

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by von Heijne, G.
Right arrow Articles by Ny, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by von Heijne, G.
Right arrow Articles by Ny, T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J. Biol. Chem., Vol. 266, Issue 23, 15240-15243, Aug, 1991

The efficiency of the uncleaved secretion signal in the plasminogen activator inhibitor type 2 protein can be enhanced by point mutations that increase its hydrophobicity

G von Heijne, P Liljestrom, P Mikus, H Andersson and T Ny
Department of Molecular Biology, Karolinska Institute, Huddinge, Sweden.

Plasminogen-activator inhibitor type 2 (PAI-2) is a specific inhibitor of plasminogen activators that belongs to the serine protease inhibitor superfamily (SERPINS). PAI-2 exists in two molecular forms: an intracellular, non-glycosylated form and a secreted, glycosylated form. Like ovalbumin, PAI-2 contains an uncleaved internal secretion signal. By deletion analysis, we have mapped the secretion signal to two mildly hydrophobic regions near the NH2 terminus. We also show that both of these regions become more efficient translocation signals when their hydrophobicities are increased. The PAI-2 secretion signal provides a unique example of a signal that, by virtue of its poor efficiency, allows the synthesis of both an extracellular and an intracellular form of the protein.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
C. Christoffersen, J. Ahnstrom, O. Axler, E. I. Christensen, B. Dahlback, and L. B. Nielsen
The Signal Peptide Anchors Apolipoprotein M in Plasma Lipoproteins and Prevents Rapid Clearance of Apolipoprotein M from Plasma
J. Biol. Chem., July 4, 2008; 283(27): 18765 - 18772.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Orsi, L. Fioriti, R. Chiesa, and R. Sitia
Conditions of Endoplasmic Reticulum Stress Favor the Accumulation of Cytosolic Prion Protein
J. Biol. Chem., October 13, 2006; 281(41): 30431 - 30438.
[Abstract] [Full Text] [PDF]


Home page
Protein Eng Des SelHome page
J. D. Bendtsen, L. J. Jensen, N. Blom, G. von Heijne, and S. Brunak
Feature-based prediction of non-classical and leaderless protein secretion
Protein Eng. Des. Sel., April 1, 2004; 17(4): 349 - 356.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Miyakawa and T. Imamura
Secretion of FGF-16 Requires an Uncleaved Bipartite Signal Sequence
J. Biol. Chem., September 12, 2003; 278(37): 35718 - 35724.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
H. Yu, F. Maurer, and R. L. Medcalf
Plasminogen activator inhibitor type 2: a regulator of monocyte proliferation and differentiation
Blood, April 15, 2002; 99(8): 2810 - 2818.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. E. Gewurz, H. L. Ploegh, and D. Tortorella
US2, a Human Cytomegalovirus-encoded Type I Membrane Protein, Contains a Non-cleavable Amino-terminal Signal Peptide
J. Biol. Chem., March 22, 2002; 277(13): 11306 - 11313.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Jankova, S. J. Harrop, D. N. Saunders, J. L. Andrews, K. C. Bertram, A. R. Gould, M. S. Baker, and P. M. G. Curmi
Crystal Structure of the Complex of Plasminogen Activator Inhibitor 2 with a Peptide Mimicking the Reactive Center Loop
J. Biol. Chem., November 9, 2001; 276(46): 43374 - 43382.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J.-M. Revest, L. DeMoerlooze, and C. Dickson
Fibroblast Growth Factor 9 Secretion Is Mediated by a Non-cleaved Amino-terminal Signal Sequence
J. Biol. Chem., March 10, 2000; 275(11): 8083 - 8090.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Miyakawa, K. Hatsuzawa, T. Kurokawa, M. Asada, T. Kuroiwa, and T. Imamura
A Hydrophobic Region Locating at the Center of Fibroblast Growth Factor-9 Is Crucial for Its Secretion
J. Biol. Chem., October 8, 1999; 274(41): 29352 - 29357.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. M. Dougherty, J. M. Pearson, A. Y. Yang, R. J. Westrick, M. S. Baker, and D. Ginsburg
The plasminogen activator inhibitor-2 gene is not required for normal murine development or survival
PNAS, January 19, 1999; 96(2): 686 - 691.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
T. M. Antalis, M. La Linn, K. Donnan, L. Mateo, J. Gardner, J. L. Dickinson, K. Buttigieg, and A. Suhrbier
The Serine Proteinase Inhibitor (Serpin) Plasminogen Activation Inhibitor Type 2 Protects against Viral Cytopathic Effects by Constitutive Interferon alpha /beta Priming
J. Exp. Med., June 1, 1998; 187(11): 1799 - 1811.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
P. A. Pemberton, A. R. Tipton, N. Pavloff, J. Smith, J. R. Erickson, Z. M. Mouchabeck, and M. C. Kiefer
Maspin Is an Intracellular Serpin That Partitions into Secretory Vesicles and Is Present at the Cell Surface
J. Histochem. Cytochem., December 1, 1997; 45(12): 1697 - 1706.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. H. Jensen, T. G. Jensen, W. E. Laug, H. Hager, J. Gliemann, and B. Pepinsky
The Exon 3Encoded Sequence of the Intracellular Serine Proteinase Inhibitor Plasminogen Activator Inhibitor 2Is a Protein Binding Domain
J. Biol. Chem., October 25, 1996; 271(43): 26892 - 26899.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Mikus and T. Ny
Intracellular Polymerization of the Serpin Plasminogen Activator Inhibitor Type 2
J. Biol. Chem., April 26, 1996; 271(17): 10048 - 10053.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. L. Scott, P. B. Coughlin, C. Bird, L. Cerruti, J. A. Hayman, and P. Bird
Proteinase Inhibitor 6 Cannot Be Secreted, Which Suggests It Is a New Type of Cellular Serpin
J. Biol. Chem., January 19, 1996; 271(3): 1605 - 1612.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. L. Dickinson, E. J. Bates, A. Ferrante, and T. M. Antalis
Plasminogen Activator Inhibitor Type 2 Inhibits Tumor Necrosis Factor alpha-induced Apoptosis
J. Biol. Chem., November 17, 1995; 270(46): 27894 - 27904.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Miura, S.-i. Kawabata, Y. Wakamiya, T. Nakamura, and S. Iwanaga
A Limulus Intracellular Coagulation Inhibitor Type 2
J. Biol. Chem., January 13, 1995; 270(2): 558 - 565.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1991 by the American Society for Biochemistry and Molecular Biology.